Expert: FDA's approval of first oral treatment for postpartum depression is a 'good advanc

Federal health officials have approved the first oral treatment for postpartum depression.

FILE - An estimated one in 7 women suffer from postpartum depression.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

komonews /  🏆 272. in US

Canada Latest News, Canada Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Opinion | Washington Stages a Peacetime Fiscal BlowoutFrom WSJopinion: The federal budget deficit is 131% higher than a year ago so far in fiscal 2023, despite a growing economy and no national emergency
Read more »

First-ever postpartum depression pill, Zurzuvae, approved by FDAThe FDA on Friday approved the first pill to treat postpartum depression, a condition that data shows affects around 1 in 7 women in the United States.
Read more »

FDA OKs Talquetamab, a First-in-Class Multiple Myeloma DrugThe FDA has granted accelerated approval to talquetamab-tgvs, a first-in-class bispecific antibody targeting the GPRC5D receptor, for heavily pretreated adults with relapsed or refractory multiplemyeloma. MedicalNews
Read more »

FDA Program Collects Birth Control Data from TeensA federal program is collecting a trove of intimate monthly birth control data on hundreds of thousands of patients, many of whom are teens, including the results of mandatory pregnancy tests.
Read more »

Nail Care ProductsPlanning on getting a manicure? Beware-some nail hardeners may contain harmful ingredients that may damage nails and cause them to break. For more information on how to use nail products safely, see nails summerfun safety
Read more »